Clinically Proven Copper Tripeptide 1

Tripeptide-1 (Copper Tripeptide-1) has been clinically proven to stimulate the synthesis of collagen in skin fibroblasts, and increase accumulation of total proteins, glycsaminogly cans and DNA in dermal wounds. The Tripeptide-1 (Copper Tripeptide-1) sequence is present in collagen and it is suggested that the Tripeptide-1 is released after tissue injury. Tripeptide-1 (Copper Tripeptide-1) also increases synthesis of decorin - a small proteoglycan in the regulation of collagen synthesis, wound healing regulation and anti-tumor defense.